Lexeo Therapeutics, Inc. Common Stock (LXEO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lexeo Therapeutics, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.33x | -2.13x | -5.39x | -4.27x | -5.00x | -49.09x |
| P/B Ratio | 2.16x | 1.79x | 3.15x | -2.24x | -4.55x | -45.69x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 386.78x | 152.66x | 487.88x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -9252.1% | -3055.9% | -884.9% |
| Net Margin | 0.0% | 0.0% | 0.0% | -9063.8% | -3055.0% | -993.8% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -8874.8% | -3054.3% | -884.9% |
| Liquidity | ||||||
| Current Ratio | 11.21x | 5.52x | 7.21x | 5.58x | 18.35x | 42.15x |
| Quick Ratio | 11.21x | 5.52x | 7.21x | 5.58x | 18.35x | 42.15x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.08x | 0.10x | -0.12x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..